Anti-Tumor Effects of Carrimycin and Monomeric Isovalerylspiramycin I on Hepatocellular Carcinoma in Vitro and in Vivo

Hepatocellular carcinoma results in a high risk of second primary malignancies and has prominent morbidity and mortality. There is a lack of effective treatment and prognosis is poor. Therefore, effective drugs need to be discovered. Carrimycin is a 16-member macrolide antibiotic with anticancer act...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yong, Zuo, Hong Xiang, Li, Ming Yue, Zhang, Zhi Hong, Xing, Yue, Wang, Jing Ying, Ma, Juan, Li, Gao, Piao, Hongxin, Gu, Puqing, Jin, Xuejun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662527/
https://www.ncbi.nlm.nih.gov/pubmed/34899336
http://dx.doi.org/10.3389/fphar.2021.774231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662527/
https://www.ncbi.nlm.nih.gov/pubmed/34899336
http://dx.doi.org/10.3389/fphar.2021.774231

Ejemplares similares